Philippe Pouletty MD Overview

  • Primary Position
  • Co-Founder & Boa...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 10

  • Med. Deal Size

  • Med. Valuation

Philippe Pouletty MD General Information

Biography

Dr. Philippe Pouletty is a Co-Founder and serves as Board Member at EVEXTA BIO. Dr. Pouletty co-founded and served as Chairman at Skinosive. He serves as a President & Board Member at PK MED. He served as Chairman and President at SpikImm. He is a Co-Founder and serves as Chief Executive Officer at Truffle Capital. He serves as a Board Member at Cellaïon. He is also a Co-Founder and serves as President and Chairman at Caranx Medical. He is also a Co-Founder and serves as a Board Member at Deinove. He served as a Board Member at Biokinésis. He is a Co-Founder and serves as Chairman at Nanosive. He Co-founded and served as a Board Member at Pharnext. He served as a Board Member of Dementia. Previously, he served as a Member of the Supervisory Board at Innate Pharma. He is a pioneer in the biotechnologies and medical devices sector with experience in both France and Silicon Valley. He is the Founder and Chairman of Deinove (Alternext: ALDEI), Co-founder and Board member of Carbios (Alternext: ALCRB), Carmat (Alternext: ALCAR), Vexim (Alternext: ALVXM), Board member of Myopowers, Kephalios, Symetis, Theraclion (Alternext: ALTHE), Theradiag (Alternext: ALTER) and Altimmune, all of which are Truffle Capital portfolio companies. He is an independent board member of Innate Pharma (Euronext). Before co-founding Truffle, He founded SangStat (1988, therapeutic for organ transplants, listed on NASDAQ in 1993, sold to Genzyme for USD 600M in 2002), and Conjuchem (founded in 1993, listed on the Toronto Stock Exchange in 2000). He is also the former Chairman (2001-2009) and current Honorary Chairman of France Biotech, the French biotech industry association, and former Vice Chairman of EuropaBio, the European biotech industry association. He conceived the Young Innovative Enterprise Status (JEI), which was implemented in France by President Chirac in 2004. He is the inventor of 29 patents, including the second-highest revenue-generating life science patent for Stanford University, earning him entry into the prestigious Stanford University Hall of Fame of Inventors in 2012. He was also awarded the Chevalier of the Légion d'Honneur. Educational qualifications: A former hematology and immunology resident in Parisian hospitals, He holds an MD from the University of Paris VI and a Master's in immunology and virology from l'Institut Pasteur, was a post-doctoral research fellow (1986-1988) at Stanford University, and the 1999 laureate of the American Liver Foundation.

Contact Information

Primary Position
Co-Founder & Board Member, EVEXTA BIO
Education
Stanford University, Post-doctoral Research
Gender
Male
Email
ph
Phone
+33 01
Address
  • 104 Boulevard de Sébastopol
  • 75003 Paris
  • France
+33 01

Philippe Pouletty MD Positions (5)

Firm name Firm type Title Location Industry Since
Caranx Medical Company Co-Founder, President and Chairman Paris, France Surgical Devices
EVEXTA BIO Company Co-Founder & Board Member Paris, France Drug Discovery
PK MED Company President & Board Member Paris, France Drug Discovery
SpikImm Company Chairman & President Paris, France Biotechnology
Truffle Capital Investor Co-Founder & Chief Executive Officer Paris, France Venture Capital

Philippe Pouletty MD Board Seats (11)

Company Industry Ownership Status Financing Status Location Since
Abivax Biotechnology Publicly Held Formerly PE-Backed Paris, France
Affluent Medical Therapeutic Devices Publicly Held Formerly PE-Backed Aix-en-Provence, France
Caranx Medical Surgical Devices Privately Held (backing) Private Equity-Backed Paris, France
Carbios Environmental Services (B2B) Publicly Held Formerly PE-Backed Clermont-Ferrand, France
Carmat Therapeutic Devices Publicly Held Formerly PE-Backed Velizy Villacoublay, France

Philippe Pouletty MD Lead Partner on Deals (41)

Philippe Pouletty MD has been the lead partner on 41 deals. Their latest deal was with Cellaïon, a drug discovery company. The deal was made on 18-Jan-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Cellaïon 18-Jan-2023 Later Stage VC Completed Drug Discovery Mont-Saint-Guibert, Belgium
Abivax 02-Sep-2022 Completed Biotechnology Paris, France
Holistick Medical 05-Apr-2021 Completed Other Devices and Supplies Paris, France
Carbios 25-Jun-2019 Completed Environmental Services (B2B) Clermont-Ferrand, France
PK MED 01-Jan-2019 Completed Drug Discovery Paris, France
Skinosive 09-Oct-2018 Completed Other Healthcare Technology Systems Paris, France
Altimmune 08-Oct-2018 Completed Drug Discovery Gaithersburg, MD
Holistick Medical 19-Dec-2017 Completed Other Devices and Supplies Paris, France
Carmat 08-Dec-2017 PIPE Completed Therapeutic Devices Velizy Villacoublay, France
Carmat 07-Jul-2017 Secondary Transaction - Open Market Completed Therapeutic Devices Velizy Villacoublay, France

Philippe Pouletty MD Network (398)

Board Members (201)

Name Company Representing Location From
William Enright Altimmune Self Gaithersburg, MD
Jose Da Gloria Affluent Medical Self Aix-en-Provence, France
Altimmune Altimmune Gaithersburg, MD
Neovacs Self Suresnes, France
Carmat Self Velizy Villacoublay, France

Portfolio Executives (183)

Name Company Role Deal date Location
René Mignolet Ph.D Cellaïon Vice President, Regulatory Affairs 18-Jan-2023 Mont-Saint-Guibert, Belgium
Eddy Rommel Ph.D Cellaïon Vice President, Preclinical Development 18-Jan-2023 Mont-Saint-Guibert, Belgium
Cellaïon President 18-Jan-2023 Mont-Saint-Guibert, Belgium
Cellaïon Vice President, Regulatory Affairs 18-Jan-2023 Mont-Saint-Guibert, Belgium
Cellaïon Chief Financial Officer & General Manager 18-Jan-2023 Mont-Saint-Guibert, Belgium

Fund Team Members (14)

Name Investor Fund Fund Location
Benjamin Rieder Truffle Capital Truffle Financial Innovation Fund Paris, France
Claire Corot Truffle Capital Truffle Medeor Fund Paris, France
Truffle Capital Paris, France
Truffle Capital Paris, France
Truffle Capital Paris, France

Philippe Pouletty MD Affiliated Funds (11)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Truffle BioMedTech Crossover Fund Truffle Capital Buyout Closed 2019
Truffle Financial Innovation Fund Truffle Capital Venture - General Closed 2019
Truffle Capital II Truffle Capital Venture - General Closed 2008
UFF Innovation 5 Truffle Capital Venture - General Liquidated 2005
UFF Innovation 8 Truffle Capital Venture - General Liquidated 2010

Philippe Pouletty MD FAQs

  • Who is Philippe Pouletty MD?

    Dr. Philippe Pouletty is a Co-Founder and serves as Board Member at EVEXTA BIO.

  • How much does Philippe Pouletty MD typically invest?

    Philippe Pouletty MD's median deal size is .

  • What is Philippe Pouletty MD’s main position?

    Philippe Pouletty MD’s primary position is Co-Founder & Board Member.

  • What are the contact details for Philippe Pouletty MD?

    Philippe Pouletty MD’s email address is ph and his phone number is +33 01 .

  • How many active board seats does Philippe Pouletty MD hold?

    Philippe Pouletty MD holds 11 board seats including Abivax, Affluent Medical, Caranx Medical, Carbios, and Carmat.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »